Dongping Mo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dongping Mo has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Xuelian Mao
Department of Clinical Laboratory, Jiangsu Cancer Hospital & Nanjing Medical University Affiliated Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, Jiangsu, 210009, People's Republic of China
5 shared publicationsCong Li
Department of Clinical Laboratory, Jiangsu Cancer Hospital & Nanjing Medical University Affiliated Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, Jiangsu, 210009, People's Republic of China
3 shared publications- Feng Yan
Department of Clinical Laboratory, The Affiliated Cancer Hospital of Nanjing Medical University and Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research, Nanjing, China
3 shared publications Lijun Zheng
Department of Clinical Laboratory, Jiangsu Cancer Hospital & Nanjing Medical University Affiliated Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, Jiangsu, 210009, People's Republic of China
3 shared publicationsYining Yang
Department of Clinical Laboratory, Jiangsu Cancer Hospital & Nanjing Medical University, Affiliated Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, People’s Republic of China
3 shared publicationsJunyu Zheng
Department of Clinical Laboratory, Jiangsu Cancer Hospital & Nanjing Medical University, Affiliated Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, People’s Republic of China
2 shared publications
Latest Publications
- Open Access
- 23 June 2026
- Published by Springer Nature in BMC Cancer
- Vol. 26 (1)
The clinical value of the combined detection of circulating low ⁃ density neutrophils and inflammatory markers in breast cancer with lymph node metastasis
Background: Breast cancer (BC) is the most prevalent cancer in women globally, with axillary lymph node metastasis (LNM) and distant metastasis being key prognostic factors linked to survival. Circulating low-density neutrophils (LDNs) in cancer patients are associated with tumor-supportive role. This study assessed the clinical relevance of combining circulating LDNs with hematological indicators in BC patients with LNM. Methods: Peripheral blood samples from 184 BC patients were analyzed using flow cytometry to measure the LDNs levels. Lasso logistic regression was used for variable selection, and univariate and multivariate logistic regression identified independent risk factors. A predictive nomogram was developed and validated with an external cohort. Results: LDNs were elevated in BC patients, especially those with LNM. Seven variables—LDNs, CEA, CA153, PLR, SIRI, NMLR, and NHR—were identified for further analysis. Multivariate logistic regression identified five of these as independent risk factors for LNM: LDNs (OR = 2.307, P = 0.032), CEA (OR = 4.027, P < 0.001), CA153 (OR = 2.440, P = 0.016), PLR (OR = 2.563, P = 0.014), and SIRI (OR = 4.617, P = 0.003). The nomogram model based on these factors demonstrated good predictive performance with an optimism-corrected C-statistic of 0.780, consistent in the external validation set (AUC = 0.762). The calibration curve confirmed good clinical applicability. Conclusion: This study suggests circulating LDNs levels may be potential biomarkers for BC progression, and a nomogram combing LDNs with other hematological indicators shows potential for identifying patients with LNM.
- 23 June 2026
- Published by Springer Nature in BMC Cancer
- Vol. 26 (1)
Open AccessThe clinical value of the combined detection of circulating low ⁃ density neutrophils and inflammatory markers in breast cancer with lymph node metastasis
Background: Breast cancer (BC) is the most prevalent cancer in women globally, with axillary lymph node metastasis (LNM) and distant metastasis being key prognostic factors linked to survival. Circulating low-density neutrophils (LDNs) in cancer patients are associated with tumor-supportive role. This study assessed the clinical relevance of combining circulating LDNs with hematological indicators in BC patients with LNM. Methods: Peripheral blood samples from 184 BC patients were analyzed using flow cytometry to measure the LDNs levels. Lasso logistic regression was used for variable selection, and univariate and multivariate logistic regression identified independent risk factors. A predictive nomogram was developed and validated with an external cohort. Results: LDNs were elevated in BC patients, especially those with LNM. Seven variables—LDNs, CEA, CA153, PLR, SIRI, NMLR, and NHR—were identified for further analysis. Multivariate logistic regression identified five of these as independent risk factors for LNM: LDNs (OR = 2.307, P = 0.032), CEA (OR = 4.027, P < 0.001), CA153 (OR = 2.440, P = 0.016), PLR (OR = 2.563, P = 0.014), and SIRI (OR = 4.617, P = 0.003). The nomogram model based on these factors demonstrated good predictive performance with an optimism-corrected C-statistic of 0.780, consistent in the external validation set (AUC = 0.762). The calibration curve confirmed good clinical applicability. Conclusion: This study suggests circulating LDNs levels may be potential biomarkers for BC progression, and a nomogram combing LDNs with other hematological indicators shows potential for identifying patients with LNM.
- Open Access
- 1 January 2026
- Published by Taylor & Francis in ImmunoTargets and Therapy
- Vol. ume 15, 1-13
The Value of the Preoperative Hematological Inflammatory Markers for Predicting Lymphovascular Invasion in Gastric Cancer
Background: Gastric cancer (GC) is a prevalent malignant tumor of the digestive system, with high morbidity and mortality. Lymphovascular invasion (LVI) is a risk factor for recurrence and metastasis of GC and an independent predictor of poor postoperative prognosis in GC patients. Accumulating evidence suggests that blood-based inflammatory indicators are linked with the pathogenesis of GC. The study delves into hematological inflammatory markers to explore their potential applications in preoperative LVI in GC. Methods: We retrospectively collected and analyzed data from inpatients diagnosed GC at our hospital from December 2020 to October 2024, with LVI confirmed by pathological examination after surgery. Preoperative hematological inflammatory indicators were calculated from peripheral blood samples. Lasso logistic regression and multivariate logistic regression analyses were utilized to verify independent risk factors for LVI-positive GC patients and constructed the nomogram model. The correlation between hematological inflammatory indicators and clinical TNM staging was assessed through Spearman’s analysis. Results: In the study, 624 patients were pathological diagnosed with LVI-positive. The variables screened by Lasso logistic regression including CA199, PLR, SII, PNI, cT staging, and cN staging. Multivariate logistic regression analysis confirmed that CA199 (OR = 1.349, 95% CI: 1.016– 1.790), PLR (OR = 1.396, 95% CI: 1.005– 1.939), PNI (OR = 0.706, 95% CI: 0.515– 0.968), cT staging (OR = 1.737, 95% CI: 1.511– 1.996) and cN staging (OR = 2.272, 95% CI: 1.975– 2.613) were independent risk factors of LVI-positive. PLR was positively correlated with cT and cN staging, while PNI was negatively correlated with both. The C-statistic of the nomogram model was 0.845, with a sensitivity of 86.86% and a specificity of 69.90%. Conclusion: We provided a new perspective on the clinical application of preoperative hematological inflammatory markers in the auxiliary diagnosis of LVI-positive in GC patients.
- 1 January 2026
- Published by Taylor & Francis in ImmunoTargets and Therapy
- Vol. ume 15, 1-13
Open AccessThe Value of the Preoperative Hematological Inflammatory Markers for Predicting Lymphovascular Invasion in Gastric Cancer
Background: Gastric cancer (GC) is a prevalent malignant tumor of the digestive system, with high morbidity and mortality. Lymphovascular invasion (LVI) is a risk factor for recurrence and metastasis of GC and an independent predictor of poor postoperative prognosis in GC patients. Accumulating evidence suggests that blood-based inflammatory indicators are linked with the pathogenesis of GC. The study delves into hematological inflammatory markers to explore their potential applications in preoperative LVI in GC. Methods: We retrospectively collected and analyzed data from inpatients diagnosed GC at our hospital from December 2020 to October 2024, with LVI confirmed by pathological examination after surgery. Preoperative hematological inflammatory indicators were calculated from peripheral blood samples. Lasso logistic regression and multivariate logistic regression analyses were utilized to verify independent risk factors for LVI-positive GC patients and constructed the nomogram model. The correlation between hematological inflammatory indicators and clinical TNM staging was assessed through Spearman’s analysis. Results: In the study, 624 patients were pathological diagnosed with LVI-positive. The variables screened by Lasso logistic regression including CA199, PLR, SII, PNI, cT staging, and cN staging. Multivariate logistic regression analysis confirmed that CA199 (OR = 1.349, 95% CI: 1.016– 1.790), PLR (OR = 1.396, 95% CI: 1.005– 1.939), PNI (OR = 0.706, 95% CI: 0.515– 0.968), cT staging (OR = 1.737, 95% CI: 1.511– 1.996) and cN staging (OR = 2.272, 95% CI: 1.975– 2.613) were independent risk factors of LVI-positive. PLR was positively correlated with cT and cN staging, while PNI was negatively correlated with both. The C-statistic of the nomogram model was 0.845, with a sensitivity of 86.86% and a specificity of 69.90%. Conclusion: We provided a new perspective on the clinical application of preoperative hematological inflammatory markers in the auxiliary diagnosis of LVI-positive in GC patients.
- Open Access
- 1 May 2025
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 18, 5979-5991
Clinical Significance of the Serum 3′tRF-AlaAGC, Neutrophil to High-Density Lipoprotein Ratio, and Lymphocyte-to-Monocyte Ratio in Breast Cancer with Lymph Node Metastasis
Objective: Breast cancer (BC) is a common malignant tumor among women, the local recurrence, lymph node metastasis (LNM), and distant metastasis are the key factors affecting the prognosis of patients. tRNA-derived small RNAs (tDRs) are non-coding small RNA fragments [16– 40 nucleotides (nt) in length] that play an important role in carcinogenesis and can serve as novel biological markers for the diagnosis and prognosis of various tumors. Accumulating evidence suggests that blood-based inflammatory indicators are linked with the pathogenesis of BC. However, the clinical significance of the combination of tDRs and inflammatory indicators in BC patients with LNM is still unclear. Methods: The serum samples were collected from 175 patients with BC admitted to our hospital during June 2021 and May 2024, and 94 age-matched healthy women, and the clinical data of the research subjects were recorded. Serum 3′tRF-AlaAGC levels were measured using quantitative real-time PCR (qRT-PCR) and the blood-based inflammatory indicators were calculated from peripheral blood samples. Lasso-cox regression and multiple logistic regression were employed for variable selection. Receiver operating characteristic (ROC) was used to calculate the cut-off value of variables. Spearman correlation test was used to examine the correlation between 3′tRF-AlaAGC levels and neutrophil to HDL-C ratio (NHR), lymphocyte-to-monocyte ratio (LMR). A nomogram model for risk assessment of LNM in BC was established by using the rms package of R software. Results: Serum 3′tRF-AlaAGC levels in BC patients with LNM were significantly higher than that in without LNM [5.17 (1.79, 16.55) vs 11.68 (2.64, 58.74), P=0.009]. The variables screened by Lasso-cox regression including 3′tRF-AlaAGC, NHR and LMR, with optimal cut-off values of 18.78, 2.94 and 5.41, respectively. NHR levels were significantly negatively associated with LMR in low 3′tRF-AlaAGC expression groups (r=− 0.209, P=0.021). Multivariate logistic regression analysis confirmed that 3′tRF-AlaAGC (OR: 3.242, 95% CI: 1.583– 6.641, P=0.001), NHR (OR: 3.305, 95% CI: 1.543– 7.079, P=0.002), and LMR (OR: 0.329, 95% CI: 0.150– 0.723, P=0.006) were independent risk factors of BC with LNM. The C-statistic of the nomograms model was 0.704, with a sensitivity of 57.14% and a specificity of 77.14%. Conclusion: 3′tRF-AlaAGC > 18.78, NHR > 2.94, and LMR ≤ 5.41 were the independent risk factors of BC with LNM. The nomogram model incorporating 3′tRF-AlaAGC, NHR and LMR can effectively predict the risk of LNM of BC patients.
- 1 May 2025
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 18, 5979-5991
Open AccessClinical Significance of the Serum 3′tRF-AlaAGC, Neutrophil to High-Density Lipoprotein Ratio, and Lymphocyte-to-Monocyte Ratio in Breast Cancer with Lymph Node Metastasis
Objective: Breast cancer (BC) is a common malignant tumor among women, the local recurrence, lymph node metastasis (LNM), and distant metastasis are the key factors affecting the prognosis of patients. tRNA-derived small RNAs (tDRs) are non-coding small RNA fragments [16– 40 nucleotides (nt) in length] that play an important role in carcinogenesis and can serve as novel biological markers for the diagnosis and prognosis of various tumors. Accumulating evidence suggests that blood-based inflammatory indicators are linked with the pathogenesis of BC. However, the clinical significance of the combination of tDRs and inflammatory indicators in BC patients with LNM is still unclear. Methods: The serum samples were collected from 175 patients with BC admitted to our hospital during June 2021 and May 2024, and 94 age-matched healthy women, and the clinical data of the research subjects were recorded. Serum 3′tRF-AlaAGC levels were measured using quantitative real-time PCR (qRT-PCR) and the blood-based inflammatory indicators were calculated from peripheral blood samples. Lasso-cox regression and multiple logistic regression were employed for variable selection. Receiver operating characteristic (ROC) was used to calculate the cut-off value of variables. Spearman correlation test was used to examine the correlation between 3′tRF-AlaAGC levels and neutrophil to HDL-C ratio (NHR), lymphocyte-to-monocyte ratio (LMR). A nomogram model for risk assessment of LNM in BC was established by using the rms package of R software. Results: Serum 3′tRF-AlaAGC levels in BC patients with LNM were significantly higher than that in without LNM [5.17 (1.79, 16.55) vs 11.68 (2.64, 58.74), P=0.009]. The variables screened by Lasso-cox regression including 3′tRF-AlaAGC, NHR and LMR, with optimal cut-off values of 18.78, 2.94 and 5.41, respectively. NHR levels were significantly negatively associated with LMR in low 3′tRF-AlaAGC expression groups (r=− 0.209, P=0.021). Multivariate logistic regression analysis confirmed that 3′tRF-AlaAGC (OR: 3.242, 95% CI: 1.583– 6.641, P=0.001), NHR (OR: 3.305, 95% CI: 1.543– 7.079, P=0.002), and LMR (OR: 0.329, 95% CI: 0.150– 0.723, P=0.006) were independent risk factors of BC with LNM. The C-statistic of the nomograms model was 0.704, with a sensitivity of 57.14% and a specificity of 77.14%. Conclusion: 3′tRF-AlaAGC > 18.78, NHR > 2.94, and LMR ≤ 5.41 were the independent risk factors of BC with LNM. The nomogram model incorporating 3′tRF-AlaAGC, NHR and LMR can effectively predict the risk of LNM of BC patients.
- Top Cited PapersOpen Access
- 1 January 2025
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 18, 813-826
The Clinical Value of the Combined Detection of Systemic Immune-Inflammation Index (SII), Systemic Inflammation Response Index (SIRI), and Prognostic Nutritional Index (PNI) in Early Diagnosis of Gastric Cancer
Objective: Gastric cancer (GC) is a common malignant tumor of the digestive tract. Accumulating studies suggest that inflammation is linked with the pathogenesis of GC. The study delves into novel hematological inflammatory markers, such as systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and prognostic nutritional index (PNI), to explore their potential applications in early diagnosis of GC. Methods: From October 2020 and August 2024, 1339 GC patients admitted to our hospital were enrolled in this study. The pre-treatment SII, SIRI, and PNI was calculated from peripheral blood samples. Univariate and multivariate logistic regression analyses were utilized to verify independent risk factors for patients, and constructed the nomograms. The correlation between hematological indicators and tumor-node-metastasis (TNM) stage was assessed through Spearman’s analysis. Results: Eligible patients and healthy controls were grouped by gender. The diagnostic ability of PNI was significantly superior to other indicators to diagnose male GC (area under the curve [AUC]=0.908, 95% CI: 0.892– 0.925) and female GC (AUC=0.890, 95% CI: 0.865– 0.914). Besides, the combination of hematological indicators is more effective in diagnosing GC patients, especially for male patients (AUC=0.916, 95% CI: 0.901– 0.932, sensitivity: 84.98%, specificity: 84.29%). The C-statistic of Nomogram model was 0.917 for males and 0.875 for females. In both male and female cohorts, CEA, SII, and SIRI were positively correlated with TNM stage, while PNI was negatively correlated. The AUC of CEA, SII, SIRI, and PNI combined for the diagnosis in the early stage of male GC patients was 0.897 (95% CI: 0.875– 0.918, sensitivity: 86.57%, specificity: 80.30%) is higher than that of in the advanced stage (AUC: 0.745, 95% CI: 0.710– 0.780, sensitivity: 56.53%, specificity: 82.86%). Conclusion: The combined CEA, SII, PNI, and SIRI could be used as screening biomarkers in diagnosing GC, especially in the early stage of male GC patients.
- 1 January 2025
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 18, 813-826
Top Cited PapersOpen AccessThe Clinical Value of the Combined Detection of Systemic Immune-Inflammation Index (SII), Systemic Inflammation Response Index (SIRI), and Prognostic Nutritional Index (PNI) in Early Diagnosis of Gastric Cancer
Objective: Gastric cancer (GC) is a common malignant tumor of the digestive tract. Accumulating studies suggest that inflammation is linked with the pathogenesis of GC. The study delves into novel hematological inflammatory markers, such as systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and prognostic nutritional index (PNI), to explore their potential applications in early diagnosis of GC. Methods: From October 2020 and August 2024, 1339 GC patients admitted to our hospital were enrolled in this study. The pre-treatment SII, SIRI, and PNI was calculated from peripheral blood samples. Univariate and multivariate logistic regression analyses were utilized to verify independent risk factors for patients, and constructed the nomograms. The correlation between hematological indicators and tumor-node-metastasis (TNM) stage was assessed through Spearman’s analysis. Results: Eligible patients and healthy controls were grouped by gender. The diagnostic ability of PNI was significantly superior to other indicators to diagnose male GC (area under the curve [AUC]=0.908, 95% CI: 0.892– 0.925) and female GC (AUC=0.890, 95% CI: 0.865– 0.914). Besides, the combination of hematological indicators is more effective in diagnosing GC patients, especially for male patients (AUC=0.916, 95% CI: 0.901– 0.932, sensitivity: 84.98%, specificity: 84.29%). The C-statistic of Nomogram model was 0.917 for males and 0.875 for females. In both male and female cohorts, CEA, SII, and SIRI were positively correlated with TNM stage, while PNI was negatively correlated. The AUC of CEA, SII, SIRI, and PNI combined for the diagnosis in the early stage of male GC patients was 0.897 (95% CI: 0.875– 0.918, sensitivity: 86.57%, specificity: 80.30%) is higher than that of in the advanced stage (AUC: 0.745, 95% CI: 0.710– 0.780, sensitivity: 56.53%, specificity: 82.86%). Conclusion: The combined CEA, SII, PNI, and SIRI could be used as screening biomarkers in diagnosing GC, especially in the early stage of male GC patients.
- Open Access
- 1 October 2024
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 13 (10) , 5381-5394
Establishment and validation of a prediction model for gastric cancer with perineural invasion based on preoperative inflammatory markers
Background: Gastric cancer (GC) is a prevalent malignant tumor of the digestive system, characterized by a poor prognosis and high recurrence rate. Perineural invasion (PNI), the neoplastic infiltration of nerves, is a significant predictor of survival outcome in GC. Accurate preoperative identification of PNI could facilitate patient stratification and optimal preoperative treatment. We therefore established and validated a preoperative risk assessment model for GC patients with PNI. Methods: We collected data from 1,195 patients who underwent surgical resection at our hospital between October 2020 and December 2023, with PNI confirmed by pathological examination. We gathered laboratory data, including blood cell count, blood type, coagulation index, biochemical indexes, and tumor markers. Eligible patients were randomly divided into a training set and a testing set at a ratio of 7:3. The important risk factors of PNI were evaluated by random forest package in RStudio. Receiver operating characteristic-area under the curve (ROC-AUC) analysis was used to evaluate the discriminatory ability of the factors for PNI. Univariate and multivariate logistic regression analyses were utilized to verity independent risk factors for patients with PNI, and the logistic regression model and nomogram were constructed based on the results. Calibration curve and decision curve analysis (DCA) were conducted to assess the predictive model. Finally, we verified the prediction equation model using the testing set. Results: In the training set, 416 GC patients were pathologically diagnosed with PNI. The top 5 important risk factors for PNI were identified as carcinoembryonic antigen (CEA), fibrinogen-to-lymphocyte ratio (FLR), D-dimer, platelet-to-lymphocyte ratio (PLR), and carbohydrate antigen 19-9 (CA19-9), with optimal cut-off values of 3.89 ng/mL, 2.08, 0.24 mg/L, 122.37, and 14.85 U/mL, respectively. Multivariate logistic regression analysis confirmed that CEA, FLR, D-dimer, PLR, CA19-9, and CA72-4 as independent risk factors for PNI (P2=105.675, PConclusions: We successfully established and validated a prediction model for GC patients with PNI based on hematological indicators, hoping that this model can provide an adjunctive tool for predicting PNI in clinical work.
- 1 October 2024
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 13 (10) , 5381-5394
Open AccessEstablishment and validation of a prediction model for gastric cancer with perineural invasion based on preoperative inflammatory markers
Background: Gastric cancer (GC) is a prevalent malignant tumor of the digestive system, characterized by a poor prognosis and high recurrence rate. Perineural invasion (PNI), the neoplastic infiltration of nerves, is a significant predictor of survival outcome in GC. Accurate preoperative identification of PNI could facilitate patient stratification and optimal preoperative treatment. We therefore established and validated a preoperative risk assessment model for GC patients with PNI. Methods: We collected data from 1,195 patients who underwent surgical resection at our hospital between October 2020 and December 2023, with PNI confirmed by pathological examination. We gathered laboratory data, including blood cell count, blood type, coagulation index, biochemical indexes, and tumor markers. Eligible patients were randomly divided into a training set and a testing set at a ratio of 7:3. The important risk factors of PNI were evaluated by random forest package in RStudio. Receiver operating characteristic-area under the curve (ROC-AUC) analysis was used to evaluate the discriminatory ability of the factors for PNI. Univariate and multivariate logistic regression analyses were utilized to verity independent risk factors for patients with PNI, and the logistic regression model and nomogram were constructed based on the results. Calibration curve and decision curve analysis (DCA) were conducted to assess the predictive model. Finally, we verified the prediction equation model using the testing set. Results: In the training set, 416 GC patients were pathologically diagnosed with PNI. The top 5 important risk factors for PNI were identified as carcinoembryonic antigen (CEA), fibrinogen-to-lymphocyte ratio (FLR), D-dimer, platelet-to-lymphocyte ratio (PLR), and carbohydrate antigen 19-9 (CA19-9), with optimal cut-off values of 3.89 ng/mL, 2.08, 0.24 mg/L, 122.37, and 14.85 U/mL, respectively. Multivariate logistic regression analysis confirmed that CEA, FLR, D-dimer, PLR, CA19-9, and CA72-4 as independent risk factors for PNI (P2=105.675, PConclusions: We successfully established and validated a prediction model for GC patients with PNI based on hematological indicators, hoping that this model can provide an adjunctive tool for predicting PNI in clinical work.
- Open Access
- 16 July 2021
- Published by Springer Nature in npj Breast Cancer
- Vol. 7 (1) , 1-12
Long non-coding RNA MIR200CHG promotes breast cancer proliferation, invasion, and drug resistance by interacting with and stabilizing YB-1
Long non-coding RNAs (lncRNA) have been identified as key regulators of tumorigenesis and development. We aim to explore the biological functions and molecular mechanisms of lncRNA MIR200CHG in breast cancer. We found that MIR200CHG is highly expressed in breast cancer tissues and is related to the tumor size and histopathological grade. In vitro and in vivo experiments confirmed that MIR200CHG can promote breast cancer proliferation, invasion, and drug resistance. MIR200CHG directly binds to the transcription factor Y-box binding protein-1 (YB-1), and inhibits its ubiquitination and degradation. MIR200CHG regulates YB-1 phosphorylation at serine 102, thereby affecting the expression of genes related to tumor cell proliferation, apoptosis, invasion, and drug resistance. Additionally, MIR200CHG partially affects the expression of miR-200c/141-3p encoded by its intron region. Therefore, MIR200CHG can promote the proliferation, invasion, and drug resistance of breast cancer by interacting with and stabilizing YB-1, and has the potential to become a target for breast cancer treatment.
- 16 July 2021
- Published by Springer Nature in npj Breast Cancer
- Vol. 7 (1) , 1-12
Open AccessLong non-coding RNA MIR200CHG promotes breast cancer proliferation, invasion, and drug resistance by interacting with and stabilizing YB-1
Long non-coding RNAs (lncRNA) have been identified as key regulators of tumorigenesis and development. We aim to explore the biological functions and molecular mechanisms of lncRNA MIR200CHG in breast cancer. We found that MIR200CHG is highly expressed in breast cancer tissues and is related to the tumor size and histopathological grade. In vitro and in vivo experiments confirmed that MIR200CHG can promote breast cancer proliferation, invasion, and drug resistance. MIR200CHG directly binds to the transcription factor Y-box binding protein-1 (YB-1), and inhibits its ubiquitination and degradation. MIR200CHG regulates YB-1 phosphorylation at serine 102, thereby affecting the expression of genes related to tumor cell proliferation, apoptosis, invasion, and drug resistance. Additionally, MIR200CHG partially affects the expression of miR-200c/141-3p encoded by its intron region. Therefore, MIR200CHG can promote the proliferation, invasion, and drug resistance of breast cancer by interacting with and stabilizing YB-1, and has the potential to become a target for breast cancer treatment.